- Yahoo Finance•2 months ago
Stocks trim gains for the month of May as strong data has traders eying the Fed. Could this week job's report push the Fed over the rate hike edge? Catch The Final Round at 4p ET with Jen Rogers and markets correspondent Nicole Sinclair.
- MarketWatch•2 months ago
Osiris Therapeutics Inc.'s stock plunged 19% in premarket trade Tuesday, after the stem cell research company disclosed in a regulatory filing late Friday that it the subject of a criminal investigation ...
Osiris Therapeutics, Inc.NasdaqGM
After hours: 5.130.00 (0.00%) as of 4:44 PM EDT
|Bid||2.00 x 100|
|Ask||5.50 x 2000|
|52wk Range||3.55 - 22.07|
|Day's Range||5.08 - 5.25|
|Avg Vol (3m)||117,525|
As of 4:00 PM EDT. Market closed.